berotek has been researched along with Malignant Melanoma in 1 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wnorowski, A | 1 |
| Sadowska, M | 1 |
| Paul, RK | 1 |
| Singh, NS | 1 |
| Boguszewska-Czubara, A | 1 |
| Jimenez, L | 1 |
| Abdelmohsen, K | 1 |
| Toll, L | 1 |
| Jozwiak, K | 1 |
| Bernier, M | 1 |
| Wainer, IW | 1 |
1 other study available for berotek and Malignant Melanoma
| Article | Year |
|---|---|
Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
Topics: Adrenergic beta-2 Receptor Agonists; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Pr | 2015 |